title: Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
authors.forename: C J
authors.initials: CJ
authors.lastname: Punt
authors.forename: S C
authors.initials: SC
authors.lastname: Henzen-Logmans
authors.forename: R L
authors.initials: RL
authors.lastname: Bolhuis
authors.forename: G
authors.initials: G
authors.lastname: Stoter
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*; D007376:Interleukin-2 / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins